# Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

> **NCT03377842** · PHASE2 · UNKNOWN · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer
- Neoadjuvant Therapy

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** apatinib and FOLFOX regimen

## Key facts

- **NCT ID:** NCT03377842
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-31
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03377842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03377842, "Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03377842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*